Printer Friendly

Compound mimics calorie restriction. (Biomedicine).

A chemical agent now under development mimics the health benefits of long-term calorie restriction and may help ward off diseases of aging such as diabetes and heart disease.

Animals whose food intake is restricted to about two-thirds of what they would otherwise consume develop diabetes and heart disease later in life than do animals that eat to their heart's content, says Barbara C. Hansen of Johns Hopkins University in Baltimore (SN: 3/15/97, p. 162). However, such severe calorie restriction isn't a likely way of preventing disease in people.

The new agent mimics a compound called peroxisome proliferator activated receptor-delta, or PPAR-delta. In the body, PPAR-delta and related compounds handle cholesterol and fat and govern cells' sensitivity to insulin (SN: 4/17/01, p. 238).

To see whether the PPAR-delta mimic wards off diseases of aging, Hansen took six middle-aged male monkeys with abnormally high concentrations of fatty acids in their blood. The animals also had abnormally low concentrations of high-density-lipoprotein-linked (HDL) cholesterol, or good cholesterol. In monkeys and people, these conditions increase the risk of heart disease. The monkeys were also less sensitive to insulin than normal, an early sign of diabetes.

After 4 weeks on the PPAR-delta mimic, the monkeys had HDL cholesterol concentrations in their blood that were on average 79 percent higher than when they started. They also had fatty acid concentrations 56 percent below their initial concentrations, and the animals' sensitivity to insulin increased over the course of the study. Moreover, the agent had no apparent side effect, Hansen reported last month at a meeting on metabolic diseases in Tempe, Ariz.

"Especially for HDL, I've never seen a more powerful agent," Hansen says.

Although the study is small, if it holds up in people, "the public health impact could be enormous," says Andrezej Bartke of Southern Illinois University in Carbondale. The new compound is already being tested in people, Hansen says.
COPYRIGHT 2002 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:peroxisome proliferator activated receptor-delta
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Feb 2, 2002
Previous Article:Biotech-crop laws were big in 2001. (Environment).
Next Article:Some new stars in the neighborhood. (Astronomy).

Related Articles
Clogged arteries block hormone effects.
Genetic variation sways risk of diabetes.
Protein may tie obesity to diabetes.
Is Peroxisome Proliferation an Obligatory Precursor Step in the Carcinogenicity of Di(2-ethylhexyl)phthalate (DEHP)?
Exposure to peroxisome proliferators: reassessment of the potential carcinogenic hazard. (Correspondence).
Mechanisms of phthalate ester toxicity in the female reproductive system.
PPAR[alpha] and effects of TCE.
PPAR[alpha] and TCE: Keshava et al. respond.
Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.
Pollutants may put on the pounds.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters